{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:35Z","timestamp":1788922175623,"version":"build-2803163510"},"reference-count":133,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["OPUS 22 2021\/43\/B\/NZ7\/00230"],"award-info":[{"award-number":["OPUS 22 2021\/43\/B\/NZ7\/00230"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008725","name":"Maj Institute of Pharmacology Polish Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00765","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:20:03Z","timestamp":1761420003000},"page":"e00765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Promising effects of astaxanthin on pain-related behaviors and morphine tolerance in a mouse model of neuropathic pain: Possible involvement of Nrf2 and the NMDA receptor subunit NR2B"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-1576","authenticated-orcid":false,"given":"Katarzyna","family":"Ciapa\u0142a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-4974","authenticated-orcid":false,"given":"Katarzyna","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5270-2758","authenticated-orcid":false,"given":"Agata","family":"Ciechanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1579-3643","authenticated-orcid":false,"given":"Wioletta","family":"Makuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-7205","authenticated-orcid":false,"given":"Joanna","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2025.e00765_bib1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"Van Hecke","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.neurot.2025.e00765_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev-pharmtox-051421-112259","article-title":"Annual review of pharmacology and toxicology neuropathic pain: mechanisms, sex differences, and potential therapies for a global problem","volume":"63","author":"Ghazisaeidi","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol is"},{"key":"10.1016\/j.neurot.2025.e00765_bib3","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.neurot.2025.e00765_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/2058738419838383","article-title":"The neuropathic pain: an overview of the current treatment and future therapeutic approaches","volume":"33","author":"Cavalli","year":"2019","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2013.01.072","article-title":"Importance of glial activation in neuropathic pain","volume":"716","author":"Mika","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neurot.2025.e00765_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jdi.12379","article-title":"Microglia in the spinal cord and neuropathic pain","volume":"7","author":"Tsuda","year":"2016","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.neurot.2025.e00765_bib8","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/glia.20871","article-title":"Microglia and neuropathic pain","volume":"57","author":"Inoue","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.neurot.2025.e00765_bib9","first-page":"1624","article-title":"Advances in neuropathic pain research: selected intracellular factors as potential targets for multidirectional analgesics","volume":"16","author":"Ciapa\u0142a","year":"2023","journal-title":"Pharm Times"},{"key":"10.1016\/j.neurot.2025.e00765_bib10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/16040","article-title":"Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity","volume":"2","author":"Ji","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2025.e00765_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0896-6273(02)00908-X","article-title":"p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia","volume":"36","author":"Ji","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2025.e00765_bib12","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1523\/JNEUROSCI.5290-05.2006","article-title":"A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance","volume":"26","author":"Zhuang","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00765_bib13","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.lfs.2006.06.023","article-title":"ERK1\/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury","volume":"79","author":"Xu","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.neurot.2025.e00765_bib14","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1523\/JNEUROSCI.21-11-03771.2001","article-title":"Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice","volume":"21","author":"Karim","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00765_bib15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1006\/mcne.2002.1205","article-title":"Noxious stimulation induces Trk receptor and downstream ERK phosphorylation in spinal dorsal horn","volume":"21","author":"Pezet","year":"2002","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neurot.2025.e00765_bib16","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1523\/JNEUROSCI.0003-06.2006","article-title":"Activated microglia contribute to the maintenance of chronic pain after spinal cord injury","volume":"26","author":"Hains","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00765_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1744-8069-3-33","article-title":"p38 MAPK, microglial signaling, and neuropathic pain","volume":"3","author":"Ji","year":"2007","journal-title":"Mol Pain"},{"key":"10.1016\/j.neurot.2025.e00765_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3959(02)00097-0","article-title":"Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus","volume":"99","author":"Ma","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.neurot.2025.e00765_bib19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1517\/14728222.9.4.699","article-title":"The ERK\/MAPK pathway, as a target for the treatment of neuropathic pain","volume":"9","author":"Ma","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.neurot.2025.e00765_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/glia.10308","article-title":"Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury","volume":"45","author":"Tsuda","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.neurot.2025.e00765_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pain.2004.12.022","article-title":"ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model","volume":"114","author":"Zhuang","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neurot.2025.e00765_bib22","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1523\/JNEUROSCI.23-10-04017.2003","article-title":"p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain","volume":"23","author":"Jin","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00765_bib23","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.lfs.2004.01.007","article-title":"MAPK activation in nociceptive neurons and pain hypersensitivity","volume":"74","author":"Obata","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.neurot.2025.e00765_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.pharep.2014.05.001","article-title":"Inhibition of intracellular signaling pathways NF-\u03baB and MEK1\/2 attenuates neuropathic pain development and enhances morphine analgesia","volume":"66","author":"Popiolek-Barczyk","year":"2014","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.neurot.2025.e00765_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6153215","article-title":"MAPK pathways are involved in neuropathic pain in rats with chronic compression of the dorsal root ganglion","volume":"2016","author":"Qu","year":"2016","journal-title":"Evidence-Based Complement Altern Med"},{"key":"10.1016\/j.neurot.2025.e00765_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104420","article-title":"Delta-Opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain","volume":"9","author":"Mika","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00765_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.01.013","article-title":"Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain","volume":"560","author":"Mika","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2013.06.005","article-title":"Minocycline influences the anti-inflammatory interleukins and enhances the effectiveness of morphine under mice diabetic neuropathy","volume":"262","author":"Zychowska","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurot.2025.e00765_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/jnc.14628","article-title":"Mitogen-activated protein kinase signaling mediates opioid-induced presynaptic NMDA receptor activation and analgesic tolerance","volume":"148","author":"Deng","year":"2019","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2025.e00765_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbi.2015.06.016","article-title":"Early single aspirin-triggered lipoxin blocked morphine anti-nociception tolerance through inhibiting NALP1 inflammasome: involvement of PI3k\/Akt signaling pathway","volume":"50","author":"Tian","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2025.e00765_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2008.12.011","article-title":"MAP kinase and pain","volume":"60","author":"Ji","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neurot.2025.e00765_bib32","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurot.2025.e00765_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.expneurol.2009.05.006","article-title":"Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model","volume":"219","author":"Gao","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurot.2025.e00765_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138583","article-title":"PD98059 influences immune factors and enhances opioid analgesia in model of neuropathy","volume":"10","author":"Rojewska","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00765_bib35","doi-asserted-by":"crossref","first-page":"107846","DOI":"10.1016\/j.pharmthera.2021.107846","article-title":"The therapeutic potential of Nrf2 inducers in chronic pain: evidence from preclinical studies","volume":"225","author":"Zhou","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neurot.2025.e00765_bib36","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.274.5288.782","article-title":"An essential role for NF-kappaB in preventing TNF-alpha-induced cell death","volume":"274","author":"Beg","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neurot.2025.e00765_bib37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1126\/science.274.5288.784","article-title":"TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB","volume":"274","author":"Wang","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neurot.2025.e00765_bib38","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1074\/jbc.273.6.3285","article-title":"p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear Factor-\u03baB p65 transactivation mediated by tumor necrosis factor","volume":"273","author":"Vanden","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2025.e00765_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/ecp.11.17","article-title":"Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain","volume":"4","author":"Zhou","year":"2011","journal-title":"Expet Rev Clin Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1756-6606-1-2","article-title":"Cingulate NMDA NR2B receptors contribute to morphine-induced analgesic tolerance","volume":"1","author":"Ko","year":"2008","journal-title":"Mol Brain"},{"key":"10.1016\/j.neurot.2025.e00765_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0028-3908(98)00218-4","article-title":"Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn","volume":"38","author":"Boyce","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2025.e00765_bib42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.expneurol.2008.10.018","article-title":"Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain","volume":"215","author":"Qu","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurot.2025.e00765_bib43","doi-asserted-by":"crossref","unstructured":"Kartha S, Yan L, Weisshaar CL, Ita ME, Shuvaev VV, Muzykantov VR, et al. Superoxide dismutase-loaded porous polymersomes as highly efficient antioxidants for treating neuropathic pain. Adv Healthcare Mater 2017;6. https:\/\/doi.org\/10.1002\/adhm.201700500. Epub ahead of print 3 September.","DOI":"10.1002\/adhm.201700500"},{"key":"10.1016\/j.neurot.2025.e00765_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1179\/135100002125000811","article-title":"Astaxanthin protects \u03b2-cells against glucose toxicity in diabetic db\/db mice","volume":"7","author":"Uchiyama","year":"2002","journal-title":"Redox Rep"},{"key":"10.1016\/j.neurot.2025.e00765_bib45","doi-asserted-by":"crossref","first-page":"112179","DOI":"10.1016\/j.biopha.2021.112179","article-title":"Anti-inflammatory action of astaxanthin and its use in the treatment of various diseases","volume":"145","author":"Kohandel","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neurot.2025.e00765_bib46","doi-asserted-by":"crossref","first-page":"155249","DOI":"10.1016\/j.phymed.2023.155249","article-title":"Astaxanthin alleviates chronic prostatitis\/chronic pelvic pain syndrome by increasing colonization of Akkermansia muciniphila in the intestine","volume":"123","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neurot.2025.e00765_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.phymed.2008.04.004","article-title":"Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: a prospective, randomized, double blind, and placebo-controlled study","volume":"15","author":"Kupcinskas","year":"2008","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neurot.2025.e00765_bib48","first-page":"502","article-title":"Astaxanthin improves fatty acid dysregulation in diabetes by controlling the AMPK-SIRT1 pathway","volume":"22","author":"Taghiyar","year":"2023","journal-title":"EXCLI J"},{"key":"10.1016\/j.neurot.2025.e00765_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/md21120643","article-title":"Dietary astaxanthin: a promising antioxidant and anti-inflammatory agent for brain aging and adult neurogenesis","volume":"21","author":"Medoro","year":"2023","journal-title":"Mar Drugs"},{"key":"10.1016\/j.neurot.2025.e00765_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/md14020035","article-title":"Potential anti-atherosclerotic properties of astaxanthin","volume":"14","author":"Kishimoto","year":"2016","journal-title":"Mar Drugs"},{"key":"10.1016\/j.neurot.2025.e00765_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/md19040201","article-title":"Molecular mechanisms of astaxanthin as a potential neurotherapeutic agent","volume":"19","author":"Bahbah","year":"2021","journal-title":"Mar Drugs"},{"key":"10.1016\/j.neurot.2025.e00765_bib52","article-title":"Multi-Mechanistic antidiabetic potential of astaxanthin: an update on preclinical and clinical evidence","volume":"65","author":"Gowd","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.neurot.2025.e00765_bib53","doi-asserted-by":"crossref","first-page":"148518","DOI":"10.1016\/j.brainres.2023.148518","article-title":"Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer\u2019s disease-related blood brain barrier dysfunction and inflammation","volume":"1819","author":"Babalola","year":"2023","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2025.e00765_bib54","first-page":"4099","article-title":"The cardioprotective effect of astaxanthin against isoprenaline-induced myocardial injury in rats: involvement of TLR4\/NF-\u03baB signaling pathway","volume":"25","author":"Zaafan","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.neurot.2025.e00765_bib55","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.3390\/molecules25225342","article-title":"Astaxanthin and its effects in inflammatory responses and inflammation-associated diseases: recent advances and future directions","volume":"25","author":"Chang","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neurot.2025.e00765_bib56","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2017.09.064","article-title":"Chronic trans-astaxanthin treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with chronic pain","volume":"662","author":"Jiang","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurot.2025.e00765_bib57","doi-asserted-by":"crossref","first-page":"9000","DOI":"10.3390\/ijms24109000","article-title":"Analgesic effects of fisetin, peimine, astaxanthin, Artemisinin, bardoxolone methyl and 740 Y-P and their influence on opioid analgesia in a mouse model of neuropathic pain","volume":"24","author":"Ciapa\u0142a","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00765_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174575","article-title":"Astaxanthin alleviates neuropathic pain by inhibiting the MAPKs and NF-\u03baB pathways","volume":"912","author":"Zhao","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib59","doi-asserted-by":"crossref","first-page":"1467788","DOI":"10.3389\/fphar.2024.1467788","article-title":"Anti-neuropathic effects of astaxanthin in a rat model of chronic constriction injury: passing through opioid\/benzodiazepine receptors and relevance to its antioxidant and anti-inflammatory effects","volume":"15","author":"Hashemi","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib60","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s43440-024-00671-9","article-title":"Astaxanthin has a beneficial influence on pain-related symptoms and opioid-induced hyperalgesia in mice with diabetic neuropathy-evidence from behavioral studies","volume":"76","author":"Ciapa\u0142a","year":"2024","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.neurot.2025.e00765_bib61","doi-asserted-by":"crossref","first-page":"156448","DOI":"10.1016\/j.phymed.2025.156448","article-title":"Astaxanthin alleviates spinal nerve ligation-induced neuropathic pain by modulating propionic acid levels","volume":"139","author":"Li","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neurot.2025.e00765_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neurot.2025.e00765_bib63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharep.2018.10.002","article-title":"Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model","volume":"71","author":"Rojewska","year":"2019","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.neurot.2025.e00765_bib64","doi-asserted-by":"crossref","first-page":"1058204","DOI":"10.3389\/fimmu.2022.1058204","article-title":"New insights into the analgesic properties of the XCL1\/XCR1 and XCL1\/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies","volume":"13","author":"Ciechanowska","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2025.e00765_bib65","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.bjp.0705427","article-title":"Antagonists of the kappa-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation","volume":"140","author":"Obara","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib66","doi-asserted-by":"crossref","first-page":"116382","DOI":"10.1016\/j.taap.2023.116382","article-title":"Effect of pharmacological modulation of the kynurenine pathway on pain-related behavior and opioid analgesia in a mouse model of neuropathic pain","volume":"461","author":"Ciapa\u0142a","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib67","doi-asserted-by":"crossref","first-page":"781310","DOI":"10.3389\/fimmu.2021.781310","article-title":"Blockade of CC chemokine receptor type 3 diminishes pain and enhances opioid analgesic potency in a model of neuropathic pain","volume":"12","author":"Pawlik","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2025.e00765_bib68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/B978-0-12-803077-6.00014-X","article-title":"Basic mouse methods for clinician researchers: harnessing the mouse for biomedical research","author":"Lambert","year":"2017","journal-title":"Basic Sci Methods Clin Res"},{"key":"10.1016\/j.neurot.2025.e00765_bib69","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cyto.2019.03.007","article-title":"Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia","volume":"119","author":"Kwiatkowski","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.neurot.2025.e00765_bib70","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0169-409X(03)00101-7","article-title":"Spinal delivery of analgesics in experimental models of pain and analgesia","volume":"55","author":"Fairbanks","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.neurot.2025.e00765_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.intimp.2018.01.011","article-title":"Astaxanthin ameliorates cerulein-induced acute pancreatitis in mice","volume":"56","author":"Zhang","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib72","doi-asserted-by":"crossref","first-page":"25073","DOI":"10.1074\/jbc.M112.378737","article-title":"Chronic opioid potentiates presynaptic but impairs postsynaptic N-Methyl-d-aspartic acid receptor activity in spinal cords","volume":"287","author":"Zhao","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2025.e00765_bib73","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1523\/JNEUROSCI.0601-23.2023","article-title":"mGluR5 from primary sensory neurons promotes opioid-induced hyperalgesia and tolerance by interacting with and potentiating synaptic NMDA receptors","volume":"43","author":"Jin","year":"2023","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00765_bib74","doi-asserted-by":"crossref","first-page":"9577874","DOI":"10.1155\/2021\/9577874","article-title":"Nrf2 activation attenuates chronic constriction injury-induced neuropathic pain via induction of PGC-1\u03b1-Mediated mitochondrial biogenesis in the spinal cord","volume":"2021","author":"Sun","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.neurot.2025.e00765_bib75","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nprot.2006.83","article-title":"The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on","volume":"1","author":"Chomczynski","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neurot.2025.e00765_bib76","first-page":"307","article-title":"Manual of pharmacologic calculations with computer programs","volume":"31","author":"Hill","year":"1982","journal-title":"J R Stat Soc Ser C"},{"key":"10.1016\/j.neurot.2025.e00765_bib77","doi-asserted-by":"crossref","first-page":"106540","DOI":"10.1016\/j.intimp.2020.106540","article-title":"Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses","volume":"84","author":"Kwiatkowski","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/cells12010098","article-title":"Pharmacological evidence of the important roles of CCR1 and CCR3 and their endogenous ligands CCL2\/7\/8 in hypersensitivity based on a murine model of neuropathic pain","volume":"12","author":"Pawlik","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neurot.2025.e00765_bib79","doi-asserted-by":"crossref","first-page":"12381","DOI":"10.1039\/D1FO02326H","article-title":"Astaxanthin alleviates inflammatory pain by regulating the p38 mitogen-activated protein kinase and nuclear factor-erythroid factor 2-related factor\/heme oxygenase-1 pathways in mice","volume":"12","author":"Zhao","year":"2021","journal-title":"Food Funct"},{"key":"10.1016\/j.neurot.2025.e00765_bib80","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neulet.2018.03.030","article-title":"Astaxanthin ameliorates behavioral and biochemical alterations in in-vitro and in-vivo model of neuropathic pain","volume":"674","author":"Sharma","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurot.2025.e00765_bib81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.brainresbull.2018.09.011","article-title":"Astaxanthin attenuates neuroinflammation contributed to the neuropathic pain and motor dysfunction following compression spinal cord injury","volume":"143","author":"Fakhri","year":"2018","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neurot.2025.e00765_bib82","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neurol.2018.08.005","article-title":"Pharmacological treatments of neuropathic pain: the latest recommendations","volume":"175","author":"Attal","year":"2019","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurot.2025.e00765_bib83","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.neurot.2025.e00765_bib84","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbi.2008.07.005","article-title":"Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice","volume":"23","author":"Mika","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2025.e00765_bib85","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3389\/fimmu.2020.01241","article-title":"CCR4 antagonist (C021) administration diminishes hypersensitivity and enhances the analgesic potency of morphine and buprenorphine in a mouse model of neuropathic pain","volume":"11","author":"Bogacka","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2025.e00765_bib86","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.brainres.2016.12.018","article-title":"Depression can be prevented by astaxanthin through inhibition of hippocampal inflammation in diabetic mice","volume":"1657","author":"Zhou","year":"2017","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2025.e00765_bib87","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S1734-1140(13)71522-6","article-title":"Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies","volume":"65","author":"Mika","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.neurot.2025.e00765_bib88","first-page":"CD014682","article-title":"Antidepressants for pain management in adults with chronic pain: a network meta-analysis","volume":"5","author":"Birkinshaw","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurot.2025.e00765_bib89","first-page":"1483","article-title":"Astaxanthin provides neuroprotection in an experimental model of traumatic brain injury via the Nrf2\/HO-1 pathway","volume":"13","author":"Gao","year":"2021","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.neurot.2025.e00765_bib90","doi-asserted-by":"crossref","first-page":"69370","DOI":"10.18632\/oncotarget.20628","article-title":"Astaxanthin acts via LRP-1 to inhibit inflammation and reverse lipopolysaccharide-induced M1\/M2 polarization of microglial cells","volume":"8","author":"Wen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neurot.2025.e00765_bib91","doi-asserted-by":"crossref","first-page":"118943","DOI":"10.1016\/j.lfs.2020.118943","article-title":"Astaxanthin inhibits microglia M1 activation against inflammatory injury triggered by lipopolysaccharide through down-regulating miR-31-5p","volume":"267","author":"Zhou","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.neurot.2025.e00765_bib92","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.2174\/0929867323666160607120124","article-title":"Targeting the microglial signaling pathways: new insights in the modulation of neuropathic pain","volume":"23","author":"Popiolek-Barczyk","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neurot.2025.e00765_bib93","doi-asserted-by":"crossref","first-page":"101876","DOI":"10.1016\/j.jchemneu.2020.101876","article-title":"Astaxanthin protects retinal ganglion cells from acute glaucoma via the Nrf2\/HO-1 pathway","volume":"110","author":"Li","year":"2020","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.neurot.2025.e00765_bib94","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15569543.2018.1452263","article-title":"Astaxanthin prevents the methotrexate-induced reproductive toxicity by targeting oxidative stress in male mice","volume":"38","author":"Heidari Khoei","year":"2019","journal-title":"Toxin Rev"},{"key":"10.1016\/j.neurot.2025.e00765_bib95","first-page":"319","article-title":"Astaxanthin protects human granulosa cells against oxidative stress through activation of NRF2\/ARE pathway and its downstream phase II enzymes","volume":"23","author":"Eslami","year":"2021","journal-title":"Cell J"},{"key":"10.1016\/j.neurot.2025.e00765_bib96","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2014.09.020","article-title":"Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model","volume":"277","author":"Rojewska","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurot.2025.e00765_bib97","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.anes.0000270759.11086.e7","article-title":"Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model","volume":"107","author":"Wen","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neurot.2025.e00765_bib98","first-page":"106","article-title":"Early intervention of ERK activation in the spinal cord can block initiation of peripheral nerve injury-induced neuropathic pain in rats. Sheng Li Xue","volume":"63","author":"Han","year":"2011","journal-title":"Bao"},{"key":"10.1016\/j.neurot.2025.e00765_bib99","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjp.0705103","article-title":"Identification of MEK1 as a novel target for the treatment of neuropathic pain","volume":"138","author":"Ciruela","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib100","doi-asserted-by":"crossref","first-page":"24417","DOI":"10.18632\/aging.203691","article-title":"RIP3 Inhibition ameliorates chronic constriction injury-induced neuropathic pain by suppressing JNK signaling","volume":"13","author":"He","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neurot.2025.e00765_bib101","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.3390\/md12126125","article-title":"Astaxanthin activates nuclear factor erythroid-related factor 2 and the antioxidant responsive element (Nrf2-ARE) pathway in the brain after Subarachnoid Hemorrhage in rats and attenuates early brain injury","volume":"12","author":"Wu","year":"2014","journal-title":"Mar Drugs"},{"key":"10.1016\/j.neurot.2025.e00765_bib102","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.neurot.2025.e00765_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00765_bib104","doi-asserted-by":"crossref","first-page":"9372182","DOI":"10.1155\/2019\/9372182","article-title":"Activators and inhibitors of NRF2: a review of their potential for clinical development","volume":"2019","author":"Robledinos-Ant\u00f3n","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.neurot.2025.e00765_bib105","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3390\/molecules27051468","article-title":"Oxidative stress and cancer heterogeneity orchestrate NRF2 roles relevant for therapy response","volume":"27","author":"Gall Tro\u0161elj","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neurot.2025.e00765_bib106","doi-asserted-by":"crossref","DOI":"10.1177\/1759091419899782","article-title":"NRF2 as a therapeutic target in neurodegenerative diseases","volume":"12","author":"Brandes","year":"2020","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neurot.2025.e00765_bib107","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.kjms.2018.03.005","article-title":"Neuroprotective effect of tanshinone IIA against neuropathic pain in diabetic rats through the Nrf2\/ARE and NF-\u03baB signaling pathways","volume":"34","author":"Feng","year":"2018","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.neurot.2025.e00765_bib108","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41401-020-0394-6","article-title":"Nrf2 activation ameliorates mechanical allodynia in paclitaxel-induced neuropathic pain","volume":"41","author":"Zhou","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.neurot.2025.e00765_bib109","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/antiox11020430","article-title":"The effects of nuclear factor Erythroid 2 (NFE2)-Related factor 2 (Nrf2) activation in preclinical models of peripheral neuropathic pain","volume":"11","author":"Basu","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.neurot.2025.e00765_bib110","article-title":"Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2025.e00765_bib111","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1535-7163.MCT-06-0516","article-title":"Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes","volume":"6","author":"Yates","year":"2007","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.neurot.2025.e00765_bib112","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tox.2014.01.008","article-title":"Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway","volume":"318","author":"Wu","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.neurot.2025.e00765_bib113","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1007\/s12035-020-01989-0","article-title":"Bardoxolone methyl ameliorates hyperglycemia induced mitochondrial dysfunction by activating the keap1-Nrf2-ARE pathway in experimental diabetic neuropathy","volume":"57","author":"Kalvala","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2025.e00765_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox10091466","article-title":"The effects of two Nrf2 activators, bardoxolone methyl and omaveloxolone, on retinal ganglion cell survival during ischemic optic neuropathy","volume":"10","author":"Chien","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.neurot.2025.e00765_bib115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/md18020085","article-title":"Haematococcus pluvialis-derived astaxanthin is a potential neuroprotective agent against optic nerve ischemia","volume":"18","author":"Lin","year":"2020","journal-title":"Mar Drugs"},{"key":"10.1016\/j.neurot.2025.e00765_bib116","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2011.09.046","article-title":"Inhibition of superoxide dismutase selectively suppresses growth of rat spinal motor neurons: comparison with phosphorylated neurofilament-containing spinal neurons","volume":"1425","author":"Isonaka","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2025.e00765_bib117","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10571-020-00952-w","article-title":"Treatment with 5-fluoro-2-oxindole increases the antinociceptive effects of morphine and inhibits neuropathic pain","volume":"41","author":"Ferreira-Chamorro","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.neurot.2025.e00765_bib118","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3389\/fphar.2018.01332","article-title":"Sulforaphane inhibited the nociceptive responses, Anxiety- and depressive-like behaviors associated with neuropathic pain and improved the anti-allodynic effects of morphine in mice","volume":"9","author":"Ferreira-Chamorro","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib119","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nurt.2009.07.008","article-title":"Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain","volume":"6","author":"Wu","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00765_bib120","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.pain.2012.02.003","article-title":"Effect of NMDA NR2B antagonist on neuropathic pain in two spinal cord injury models","volume":"153","author":"Kim","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.neurot.2025.e00765_bib121","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.neurot.2025.e00765_bib122","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1460-9568.2005.04340.x","article-title":"Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain","volume":"22","author":"Abe","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00765_bib123","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4137\/IJTR.S2318","article-title":"Effects of kynurenine pathway metabolites on intracellular NAD+ synthesis and cell death in human primary astrocytes and neurons","volume":"2","author":"Braidy","year":"2009","journal-title":"Int J Tryptophan Res"},{"key":"10.1016\/j.neurot.2025.e00765_bib124","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.36076\/ppj.2020\/23\/E41","article-title":"An analysis of biomarkers in patients with chronic pain","volume":"23","author":"Gunn","year":"2020","journal-title":"Pain Physician"},{"key":"10.1016\/j.neurot.2025.e00765_bib125","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0165-6147(00)01863-0","article-title":"NMDA receptor antagonists as analgesics: focus on the NR2B subtype","volume":"22","author":"Chizh","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurot.2025.e00765_bib126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1744-8069-7-8","article-title":"Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats","volume":"7","author":"Mihara","year":"2011","journal-title":"Mol Pain"},{"key":"10.1016\/j.neurot.2025.e00765_bib127","doi-asserted-by":"crossref","first-page":"e1652","DOI":"10.1212\/WNL.0000000000007238","article-title":"NMDA receptor antagonists and pain relief: a meta-analysis of experimental trials","volume":"92","author":"Thompson","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2025.e00765_bib128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40263-019-00618-2","article-title":"Expanding role of NMDA receptor antagonists in the management of pain","volume":"33","author":"Kreutzwiser","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neurot.2025.e00765_bib129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12094","article-title":"Ketamine for chronic pain: risks and benefits","volume":"77","author":"Niesters","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00765_bib130","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.3390\/ijms24065336","article-title":"The effect of ketamine on endoplasmic reticulum stress in rats with neuropathic pain","volume":"24","author":"Seo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00765_bib131","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/jsfa.13019","article-title":"Preparation of astaxanthin-loaded composite micelles with coaxial electrospray technology for enhanced oral bioavailability and improved antioxidation capability","volume":"104","author":"Liao","year":"2024","journal-title":"J Sci Food Agric"},{"key":"10.1016\/j.neurot.2025.e00765_bib132","doi-asserted-by":"crossref","first-page":"895","DOI":"10.12688\/f1000research.138477.1","article-title":"A randomized interventional clinical trial assessing the safety and effectiveness of PeaNoc XL tablets in managing joint pain and inflammation in arthritis patients","volume":"12","author":"Kadanangode Narayanaswam","year":"2023","journal-title":"F1000Research"},{"key":"10.1016\/j.neurot.2025.e00765_bib133","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/nu12040956","article-title":"FlexPro MD\u00ae, a combination of krill oil, astaxanthin and hyaluronic acid, reduces pain behavior and inhibits inflammatory response in monosodium iodoacetate-induced osteoarthritis in rats","volume":"12","author":"Park","year":"2020","journal-title":"Nutrients"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:48:40Z","timestamp":1773265720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":133,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1878747925002430"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00765","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising effects of astaxanthin on pain-related behaviors and morphine tolerance in a mouse model of neuropathic pain: Possible involvement of Nrf2 and the NMDA receptor subunit NR2B","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Maj Institute of Pharmacology Polish Academy of Sciences. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00765"}}